Convolvamine hydrochloride
CAS: 5896-59-3
Ref. 3D-FAA89659
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Información del producto
Convolvamine hydrochloride is a drug candidate for the treatment of Alzheimer's disease. It binds to intracellular lipid, which is a target protein in Alzheimer's disease. Convolvamine hydrochloride has been shown to inhibit the production of beta-amyloid and tau proteins, which are involved in the progression of Alzheimer's disease. The drug candidate also inhibits proteolytic enzymes that degrade extracellular amyloid precursor protein (APP). This inhibition prevents APP from being processed into beta-amyloid, thereby reducing levels of this toxic protein. Convolvamine hydrochloride also inhibits phospholipase A2, which may be an important step in preventing inflammation in the brain.
Propiedades químicas
Consulta técnica sobre: 3D-FAA89659 Convolvamine hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
